Effect of Cellular Therapy in progression of Becker's Muscular Dystrophy: A Case study

被引:4
|
作者
Sharma, Alok [1 ]
Sane, Hemangi [2 ]
Gokulchandra, Nandini [1 ]
Sharan, Rishabh [2 ]
Paranjape, Amruta [3 ]
Kulkarni, Pooja [2 ]
Yadav, Jayanti [3 ]
Badhe, Prerna [1 ]
机构
[1] NeuroGen Brain & Spine Inst, Dept Med Serv & Clin Res, Mumbai, Maharashtra, India
[2] NeuroGen Brain & Spine Inst, Dept Res & Dev, Mumbai, Maharashtra, India
[3] NeuroGen Brain & Spine Inst, Dept Neurorehabil, Mumbai, Maharashtra, India
关键词
Autologous Bone Marrow; Mononuclear cells; Becker Muscular Dystrophy; Manual muscle strength;
D O I
10.4081/ejtm.2016.5522
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Becker muscular dystrophy (BMD) is an inherited disorder due to deletions of the dystrophin gene that leads to muscle weakness. Effects of bone marrow mononuclear cell (BMMNC) transplantation in Muscular Dystrophy have shown to be safe and beneficial. We treated a 20-year-old male suffering from BMD with autologous BMMNC transplantation followed by multidisciplinary rehabilitation. He presented with muscle weakness and had difficulty in performing his activities. The BMMNCs were transplanted via intrathecal and intramuscular routes. The effects were measured on clinical and functional changes. Over 9 months, gradual improvement was noticed in muscle strength, respiratory functions and North Star Ambulatory Assessment Scale. Functional Independence Measure, Berg Balance Score, Brooke and Vignos Scale remained stable indicating halting of the progression. The case report suggests that cellular therapy combined with rehabilitation may have possibility of repairing and regenerating muscle fibers and decreasing the rate of progression of BMD.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 50 条
  • [1] Progression of a Case of Myocardial Damage Caused by Becker's Muscular Dystrophy
    Ise, Takayuki
    Iwase, Takashi
    Yamada, Hirotsugu
    Yagi, Shusuke
    Tobiume, Takeshi
    Yamaguchi, Koji
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Masashi, Akaike
    Sata, Masataka
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S172 - S172
  • [2] Prednisone therapy in Becker's muscular dystrophy
    Johnsen, SD
    Johnson, PC
    ANNALS OF NEUROLOGY, 1996, 40 (02) : 163 - 163
  • [3] Prednisone therapy in Becker's muscular dystrophy
    Johnsen, SD
    JOURNAL OF CHILD NEUROLOGY, 2001, 16 (11) : 870 - 871
  • [4] Becker's muscular dystrophy: A case report
    Seid, D
    ETHIOPIAN MEDICAL JOURNAL, 1997, 35 (01) : 63 - 65
  • [5] A case of fascioscapulohumeral muscular dystrophy misdiagnosed as Becker's muscular dystrophy for 20 years
    Ramos, Vesper Fe Marie Llaneza
    Thaisetthawatkul, Pariwat
    AGE AND AGEING, 2012, 41 (02) : 273 - 274
  • [6] CASE OF BETHLEM MYOPATHY MISDIAGNOSED AS BECKER'S MUSCULAR DYSTROPHY
    Singh, Neeraj
    Reid, Derrece
    MUSCLE & NERVE, 2018, 58 : S70 - S70
  • [7] A case of Bartter's syndrome, gout and Becker's muscular dystrophy
    Fishel, B
    Zhukovsky, G
    Legum, C
    Jossiphov, J
    Alon, M
    Peer, G
    Iaina, A
    Nevo, Y
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (03) : 426 - 427
  • [8] Role of Ayurveda in the management of becker muscular dystrophy: A case study
    Bohra, Mohita
    ANCIENT SCIENCE OF LIFE, 2024, 38 (3-4) : 173 - 176
  • [9] Follistatin Gene Therapy for Becker Muscular Dystrophy
    Mendell, J. R.
    Sahenk, Z.
    Rodino-Klapac, L. R.
    Clark, K. R.
    Lewis, K. R.
    Shontz, K.
    Al-Zaidy, S.
    Alfano, L.
    Lowes, L. P.
    Berry, K.
    Malik, V.
    Shilling, C. J.
    Rosales, X. Q.
    Walker, C. M.
    Flanigan, K. M.
    Hogan, M.
    Kaspar, B. K.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 923 - 923
  • [10] Cardiac Resynchronization Therapy in Becker Muscular Dystrophy
    Andrikopoulos, George
    Kourouklis, Spiros
    Trika, Chrysanthi
    Tzeis, Stylianos
    Rassias, Ioannis
    Papademetriou, Christos
    Katsivas, Apostolos
    Theodorakis, George
    HELLENIC JOURNAL OF CARDIOLOGY, 2013, 54 (03) : 227 - 229